AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA
3.9800
04-October-24 15:59:55
15 minutes delayed
Stocks
+0.0800
+2.05%
Today's range
3.8400 - 3.9900
ISIN
N/A
Source
NASDAQ
-
Autolus Therapeutics to participate in upcoming virtual investor conferences
02 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
-
01 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
-
09 Aug 2021 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Second Quarter 2021 Financial Results and Operational Progress
05 Aug 2021 07:00:02 By Nasdaq GlobeNewswire
-
02 Aug 2021 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Announces Appointment of Edgar Braendle, M.D., Ph.D., as Chief Development Officer
15 Jul 2021 07:00:00 By Nasdaq GlobeNewswire
-
08 Jul 2021 07:00:00 By Nasdaq GlobeNewswire
-
15 Jun 2021 07:00:01 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces an Additional Nature Publication for AUTO1
25 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Autolus Notice of Annual General Meeting (AGM) on Friday, June 18, 2021
21 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
12 May 2021 10:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports First Quarter 2021 Financial Results and Operational Progress
06 May 2021 07:00:02 By Nasdaq GlobeNewswire
-
26 Apr 2021 07:00:01 By Nasdaq GlobeNewswire
-
20 Apr 2021 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces appointment of Martin Murphy as Non-executive Chairman
19 Apr 2021 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics to Participate in Investor Conferences Through April
01 Apr 2021 16:01:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment of adult ALL
01 Apr 2021 08:45:42 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations
29 Mar 2021 08:00:00 By Nasdaq GlobeNewswire
-
04 Mar 2021 07:00:01 By Nasdaq GlobeNewswire